Schimmel

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Jackie Schimmel's The Bitch Bible Podcast, Further Strengthening PodcastOne’s Thriving Network of Female Focused Programming

Retrieved on: 
Monday, March 4, 2024
Acquisition, Sony Television, Dares Phrygius, Television, Woman, LOS, IHeartRadio, NBCUniversal, News, PODC, Culture, Thought, Growth, Female, The Adam Carolla Show, HuffPost, 3 Arts Entertainment, Food, Blog, Universal, Human, NBC, Apple Podcasts, Entertainment Weekly, Mama, Intuition, Jackie, Amazon, Schimmel, UCLA, Creative Artists Agency, Publication, LVO, Partnership, Music

LOS ANGELES, CA, March 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), which owns ~73% of the PODC outstanding common stock, announced today that it has acquired the exclusive sales and distribution rights to Jackie Schimmel’s The Bitch Bible Podcast. This acquisition allows the podcast to immediately become a cornerstone of PodcastOne’s flourishing and growing network of programming for women.

Key Points: 
  • This acquisition allows the podcast to immediately become a cornerstone of PodcastOne’s flourishing and growing network of programming for women.
  • As part of the newly announced partnership, Schimmel will begin to create video elements as a companion to her audio-based podcast.
  • “PodcastOne is thrilled to welcome Jackie and The Bitch Bible to the network.
  • PodcastOne shows are available through PodcastOne , Apple Podcasts, Spotify, iHeart, Amazon and wherever podcasts are heard.

Alnylam Announces Changes to its Board of Directors

Retrieved on: 
Thursday, February 27, 2020
Biotechnology, Other Health, Health, Genetics, Pharmaceutical, Companies, Business, Alnylam Pharmaceuticals, Therapeutic gene modulation, Corporations, Advisory board, Paul Schimmel, Board of directors, Schimmel

In addition, Alnylam announces today the retirement of Dr. Paul Schimmel from the Board effective upon the conclusion of his current term at the Annual Meeting of Alnylam stockholders in 2020.

Key Points: 
  • In addition, Alnylam announces today the retirement of Dr. Paul Schimmel from the Board effective upon the conclusion of his current term at the Annual Meeting of Alnylam stockholders in 2020.
  • Schimmel co-founded Alnylam where he served on the Board of Directors and Scientific Advisory Board since the Companys founding in 2002.
  • Following his retirement from the Board of Directors, Dr. Schimmel will continue to serve on the Companys Scientific Advisory Board.
  • We are honored to welcome Olivier to our Board of Directors at this exciting point in Alnylams history.